USE OF CCR5 ANTAGONISTS ALONE OR IN COMBINATION THERAPY FOR THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG

发明人:

Niels HALAMA,Dirk JÄGER,Inka ZOERNIG,Niels GRABE

申请号：

US15522113

公开号：

US20180289689A1

申请日:

2015.10.27

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention relates to CCRS antagonists for use in the treatment of cancer, either in monotherapy or in combination therapy. The invention also relates to methods for determining whether a subject suffering from cancer benefits from an ongoing therapeutic treatment with a CCRS antagonist or whether a subject suffering from cancer will benefit from a planned therapeutic treatment with a CCRS antagonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/